期刊文献+

非典型性肺炎病毒S蛋白受体结合域的可溶性表达

Soluble Expression the Receptor Binding Domain of Spike Protein of SARS Virus
下载PDF
导出
摘要 试验目的是获得S蛋白受体结合域基因,并获得其高效表达,为SARS病毒受体的进一步研究奠定一定的基础。首先通过PCR方法获得了S蛋白起始密码和SalⅠ限制性内切酶之间包含受体结合区的片段,然后将该基因定向克隆到pET-22b原核表达载体,构建了pET-22b-S1重组质粒,转化大肠杆菌并诱导目的蛋白的表达,经SDS-PAGE没有发现明显的目的蛋白带。利用载体和S1基因上的NcoⅠ酶切位点,将S1基因的信号肽序列和部分疏水序列切掉后,构建pET-22b-SNS重组质粒。pET-22b-SNS重组质粒仍然包含受体结合域序列,并且阅读框没有改变。将pET-22b-SNS转化大肠杆菌,发现明显的目的蛋白带。Western blot结果表明表达蛋白为SARS病毒S1蛋白的一部分。 In order to get an efficient way to express SARS receptor binding domain, the S1 gene fragment was amplified through PCR and ligated to pEr- 22b directly. The recombinant vector was transformed into E. coli BL21 and induced with IPTG, but the target protein was not detected. Taking advantage of the restriction endonudease Nco Ⅰ of S1 gene and pEr- 22b, the signal sequence and some hydrophobic part of S1 gene were cut off to get another recombinant vector pEr- 22b- SNS. The recombinant vector which contained the gene fragment between restriction endonucleaso Nco Ⅰ and Sal Ⅰ of S1 gent was expressed successfully in E. coli BL21 and the expressed protein was mostly soluble. The Western blot experiment showed it reacted well with the polyolone antibody of SARS.
出处 《生物技术》 CAS CSCD 2005年第6期20-22,共3页 Biotechnology
关键词 非典型性肺炎病毒 S1蛋白 大肠杆菌 表达 SARS S1 protein E. coli expression
  • 相关文献

参考文献9

  • 1Gao W,Tamin A,Soloff A,et al.Effects of a SARS-associated coronavirus vaccine in monkeys[J].Lancet,2003,362:1895-1896.
  • 2Krokhin O,Li Y,Andonov A,et al.Mass spectroometric characterization of proteins from the SARS virus:a preliminary report[J].Mol.Cell.Proteom,2003,2:346-356.
  • 3Liu Shuwen,Xiao Gengfu,Chen Yibang,et al.Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavius:implications for virus fusogenic mechanism and identification of fusion inhibitors[J].Lancet,2004,363:938-947.
  • 4Li W,Moore M J,Vasilieva N,et al.Angiotensin-converting enzyme 2is a functional recptor for the SARS coronavirus[J].Nature,2003,426:450-454.
  • 5Xiao Xiaodong,Samitabh C,Anthony S D,The SARS-COV S glycoprotein:expression and functional characterization[J].Biochemical and Biophysical Research Communications,2003,312:1159-1164.
  • 6萨姆布鲁克J 弗里奇EF 曼尼阿蒂斯T.分子克隆实验指南(第2版)[M].北京:科学出版社,1992.16-69.
  • 7Wong S K,Li W,Moore M J,Choe H M,et al.A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2[J].J.Biol.Chem,2004,279:3197-3201.
  • 8Bosch B J,Vander Z R,Haan C A,et al.The coronavirus spike protein is a class I virus fusion protein:structural and functional characterization of the fusion corecomplex[J].J.Virol,2003,77:8801-8811.
  • 9Ho TinYun,Wu ShihLu,Cheng ShinEi,et al.Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein[J].Biochemical and Biophysical Research Communications,2004,313:938-947.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部